1 "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Nov 10, 2024
Read More Apparatus The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise! Mar 22, 2025
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Mar 31, 2025
Read More Medical Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives! Mar 18, 2025
